Category
Etoposide
CAS Number
33419-42-0
Molecular Formula
C29H32O13
Molecular Weight
588.6 g/mol
Synonym

(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-ethane-1,1-diyl]-beta-D-glucopyranosyl]oxy]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydro[2]benzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one ; Furo[3`,4`:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S);

Keywords
Chiral standards
Intermediates
Heterocycles
Pharmaceutical Standards
Fine Chemicals
slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Etoposide is used in the treatment of several malignancies, including testicular cancer, small cell lung cancer, lymphomas, and leukemias, often as part of combination chemotherapy. It is also applied in pharmaceutical analysis as a reference standard for method development and quality control.